Agilent Technologies, Inc. - stock earnings

A Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 28, 2024 BeforeMarket - / 1.1900000000 - - / 1.6 billion -

A Quarterly earnings

DateEarningsRevenue
2023Q3 111.0 million USD 1.7 billion USD
2023Q1 352.0 million USD 1.8 billion USD
2022Q4 368.0 million USD 1.8 billion USD
2022Q3 329.0 million USD 1.7 billion USD
2022Q2 274.0 million USD 1.6 billion USD
2022Q1 283.0 million USD 1.7 billion USD
2021Q4 442.0 million USD 1.7 billion USD
2021Q3 264.0 million USD 1.6 billion USD
2021Q2 216.0 million USD 1.5 billion USD
2021Q1 288.0 million USD 1.5 billion USD
2020Q4 222.0 million USD 1.5 billion USD

A Yearly earnings

DateEarningsRevenue
2023 1.2 billion USD 6.8 billion USD
2022 1.3 billion USD 6.8 billion USD
2021 1.2 billion USD 6.3 billion USD
2020 719.0 million USD 5.3 billion USD
2019 1.1 billion USD 5.2 billion USD
2018 316.0 million USD 4.9 billion USD
2017 684.0 million USD 4.5 billion USD
2016 460.0 million USD 4.2 billion USD
2015 398.0 million USD 4.0 billion USD
2014 497.0 million USD 7.0 billion USD
2013 724.0 million USD 6.8 billion USD
2012 1.2 billion USD 6.9 billion USD
2011 1.0 billion USD 6.6 billion USD
2010 624.0 million USD 5.4 billion USD
2009 -31.0 million USD 4.5 billion USD
2008 693.0 million USD 5.8 billion USD
2007 638.0 million USD 5.4 billion USD
2006 3.3 billion USD 5.0 billion USD
2005 327.0 million USD 5.1 billion USD
2004 349.0 million USD 7.2 billion USD
2003 -2.1 billion USD 6.1 billion USD
2002 -1.0 billion USD 6.0 billion USD
2001 168.0 million USD 8.4 billion USD
2000 757.0 million USD 10.8 billion USD
1999 512.0 million USD 8.3 billion USD
1998 257.0 million USD 8.0 billion USD

A

List: Contenders

Price: $137.52

52 week price:
96.80
151.58

Dividend Yield: 0.01%

5-year range yield:
0.01%
0.99%

Forward Dividend Yield: 0.69%

Payout Ratio: 22.53%

Payout Ratio Range:
9.10%
67.63%

Dividend Per Share: 0.94 USD

Earnings Per Share: 4.18 USD

P/E Ratio: 31.74

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.7 million

Ebitda: 304.0 million

Market Capitalization: 42.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 13

DGR3: 7.17%

DGR5: 7.91%

DGR10: 9.16%

Links: